Visualize, Analyze, Understand Medical Images
MIPAV (nih.gov) scores 67 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, in the 15th percentile of 15158 Healthcare brands.
MIPAV (Medical Image Processing, Analysis, and Visualization) is a software application developed within the U.S. National Institutes of Health, under the Department of Health and Human Services, to help researchers quantitatively analyze and visualize medical images from modalities such as PET, MRI, CT, and microscopy. It provides a standardized interface that allows researchers at different institutions to share data and analyses, supporting collaborative medical research aimed at improving diagnosis and treatment of disease.
| Brand Name | MIPAV |
|---|---|
| Domain | nih.gov |
| Industry | Healthcare, Technology |
| Founded | 1887 |
| Headquarters | Bethesda |
| Parent Company / Owner | United States Department of Health and Human Services |
| CEO | Lawrence A. Tabak |
| Main Competitors | 3D Slicer (85/100), ITK-SNAP (62/100), OsiriX (81/100), Horos (80/100), ImageJ/Fiji (76/100), Mimics (Materialise) (80/100), Analyze (AnalyzeDirect) (73/100) |
Moz Domain Authority 95/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
MIPAV appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "To provide researchers with powerful tools for quantitative analysis and visualization of medical images across multiple modalities to enhance research, diagnosis, and treatment of…" (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is PubMed?", Claude could identify the brand as of August 2026. PubMed is a free search engine developed by the National Library of Medicine (part of NIH) that provides access to millions of citations and abstracts from biomedical and life sciences literature, including MEDLINE. Best known for Being the go-to free database for searching biomedical research papers and abstracts.
When asked "Best brands similar to PubMed?", Claude would recommend MIPAV as of August 2026. It's the standard reference tool for medical literature searches, so it would naturally come up for anyone looking for trusted healthcare research databases.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
MIPAV's main competitors in Healthcare: 3D Slicer (85/100), ITK-SNAP (62/100), OsiriX (81/100), Horos (80/100), ImageJ/Fiji (76/100).
Sources: Brand Analyzer scan
MIPAV has limited AI-search visibility, scoring 36/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 44, recommendation 60). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: MIPAV official site
MIPAV was founded in 1887. MIPAV operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
MIPAV is headquartered in Bethesda. MIPAV operates in the Healthcare category.
Sources: Wikidata
MIPAV provides researchers with tools to process, quantitatively analyze, and visualize medical images from multiple imaging modalities, including PET, MRI, CT, and microscopy. It offers a standardized interface that allows users at different research sites to share data and analyses, supporting collaborative studies aimed at improving diagnosis and treatment of medical disorders.
Sources: MIPAV official site
MIPAV scores 60/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: MIPAV official site
MIPAV offers a software application for quantitative analysis and visualization of medical images across modalities such as PET, MRI, CT, and microscopy, including standardized tools for data sharing and collaborative analysis among researchers.
Sources: MIPAV official site
MIPAV (Medical Image Processing, Analysis, and Visualization) is a software tool developed by the U.S. National Institutes of Health for quantitative analysis and visualization of medical images. It is provided free of charge to researchers and operates under the U.S. Department of Health and Human Services.
Sources: MIPAV official site
MIPAV can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: MIPAV official site
MIPAV is owned by or part of United States Department of Health and Human Services. MIPAV operates in the Healthcare category.
Sources: Wikidata
MIPAV is used by medical researchers, scientists, and clinicians who need to process, analyze, and visualize medical images for research, diagnostic, and treatment purposes.
Sources: MIPAV official site
MIPAV is known for being a free, NIH-developed medical imaging application that supports multiple imaging modalities and enables standardized, collaborative analysis of medical images across research institutions.
Sources: MIPAV official site
MIPAV scores 36/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
MIPAV has a weak AI-visibility profile at 36/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (60/100) and its weakest is visibility (18/100). It benefits from a Moz Domain Authority of 95/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify MIPAV from memory (August 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
67 in October 2026, down from 79 in August 2026.
Ranked closest to MIPAV: NHS Business Services Authority (NHSBSA) (67/100), New Horizon Family Health Services (67/100), Medical (67/100), Nimblemind (67/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.